Too Many Unknowns In Preclinical Testing Of Percutaneous Valves – FDA
This article was originally published in The Gray Sheet
Executive Summary
FDA is encouraging collaboration among industry, clinicians and other experts to develop preclinical tests for percutaneous heart valve replacements
You may also be interested in...
St. Jude Unveils Plan To Launch Transcatheter Aortic Valve By 2012
St. Jude Medical plans to begin clinical trials of a transcatheter aortic heart valve system by the end of 2010, with the goal of earning a CE mark for European marketing in mid-2012
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.